Literature DB >> 24665457

Chronic myeloid leukemia: When the going gets tough.

Lucy A Pickard1, Graham Knee2, Vishal Jayakar1.   

Abstract

Entities:  

Year:  2014        PMID： 24665457      PMCID： PMC3961880          DOI： 10.4103/2278-330X.126574

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN： 2278-330X


× No keyword cloud information.
  3 in total

1.  Ponatinib in refractory Philadelphia chromosome-positive leukemias.

Authors:  Jorge E Cortes; Hagop Kantarjian; Neil P Shah; Dale Bixby; Michael J Mauro; Ian Flinn; Thomas O'Hare; Simin Hu; Narayana I Narasimhan; Victor M Rivera; Tim Clackson; Christopher D Turner; Frank G Haluska; Brian J Druker; Michael W N Deininger; Moshe Talpaz
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

Review 2.  Optimizing the selection of kinase inhibitors for chronic myeloid leukemia patients.

Authors:  Devendra K Hiwase; David T Yeung; Deborah L White
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

3.  Targeted therapy and the T315I mutation in Philadelphia-positive leukemias.

Authors:  Simona Soverini; Ilaria Iacobucci; Michele Baccarani; Giovanni Martinelli
Journal:  Haematologica       Date:  2007-04       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.